September 10, 2020 Comments Off on Patent delisted for Boehringer Ingelheim drug TRIJARDY XR Posted in: Uncategorized
Annual Drug Patent Expirations for TRIJARDY+XR Trijardy Xr is a drug marketed by Boehringer Ingelheim and is included in one NDA. It is available from one supplier. There are fifteen…
The post Patent delisted for Boehringer Ingelheim drug TRIJARDY XR a…
September 10, 2020 Comments Off on Patent delisted for Taiho Oncology drug LONSURF Posted in: Uncategorized
Annual Drug Patent Expirations for LONSURF Lonsurf is a drug marketed by Taiho Oncology and is included in one NDA. It is available from one supplier. There are five patents…
The post Patent delisted for Taiho Oncology drug LONSURF appeared first on Dr…
